Sabra Healthcare REIT, Inc. $SBRA is Engineers Gate Manager LP’s 4th Largest Position

Engineers Gate Manager LP lowered its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 25.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,544,219 shares of the real estate investment trust’s stock after selling 1,513,777 shares during the period. Sabra Healthcare REIT comprises 1.0% of Engineers Gate Manager LP’s investment portfolio, making the stock its 4th biggest position. Engineers Gate Manager LP owned approximately 1.82% of Sabra Healthcare REIT worth $86,068,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of SBRA. Rothschild Investment LLC raised its position in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 889 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Sabra Healthcare REIT by 97.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares in the last quarter. Founders Capital Management acquired a new stake in Sabra Healthcare REIT in the 3rd quarter valued at about $28,000. Strengthening Families & Communities LLC acquired a new stake in Sabra Healthcare REIT in the 4th quarter valued at about $29,000. Finally, Danske Bank A S acquired a new stake in Sabra Healthcare REIT in the 3rd quarter valued at about $30,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 2.7%

Shares of Sabra Healthcare REIT stock opened at $18.05 on Thursday. The company has a fifty day simple moving average of $19.98 and a 200-day simple moving average of $19.67. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $21.28. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The stock has a market cap of $4.55 billion, a price-to-earnings ratio of 28.65, a PEG ratio of 1.38 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter in the prior year, the business posted $0.37 EPS. The company’s revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were issued a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.6%. Sabra Healthcare REIT’s dividend payout ratio is presently 190.48%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on SBRA. Scotiabank increased their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “sector perform” rating in a research report on Thursday, May 21st. Raymond James Financial began coverage on Sabra Healthcare REIT in a report on Wednesday. They issued an “underperform” rating on the stock. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Monday, May 18th. Truist Financial increased their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Finally, Cantor Fitzgerald increased their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Five analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $22.40.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.